Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

JMAC

Maxpro Capital Acquisition (JMAC)

Maxpro Capital Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:JMAC
DateTimeSourceHeadlineSymbolCompany
04/10/20238:01AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:JMACMaxpro Capital Acquisition Corporation
03/31/20233:01PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
03/30/20237:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
03/30/20237:00AMGlobeNewswire Inc.Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on NasdaqNASDAQ:JMACMaxpro Capital Acquisition Corporation
03/29/20234:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACMaxpro Capital Acquisition Corporation
03/29/20234:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACMaxpro Capital Acquisition Corporation
03/29/20233:25PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:JMACMaxpro Capital Acquisition Corporation
03/29/20233:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACMaxpro Capital Acquisition Corporation
03/21/20233:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
02/14/20233:56PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JMACMaxpro Capital Acquisition Corporation
02/13/20233:08PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JMACMaxpro Capital Acquisition Corporation
02/10/20236:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
01/13/20233:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
01/13/20233:13PMGlobeNewswire Inc.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business CombinationNASDAQ:JMACMaxpro Capital Acquisition Corporation
01/10/20233:32PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
01/10/20233:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
01/10/20233:05PMGlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business CombinationNASDAQ:JMACMaxpro Capital Acquisition Corporation
11/15/20227:00AMGlobeNewswire Inc.Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor AberrationsNASDAQ:JMACMaxpro Capital Acquisition Corporation
10/14/20223:59PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
10/14/20223:54PMGlobeNewswire Inc.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business CombinationNASDAQ:JMACMaxpro Capital Acquisition Corporation
10/07/20223:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
10/07/20223:05PMGlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business CombinationNASDAQ:JMACMaxpro Capital Acquisition Corporation
09/15/20225:22AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
09/14/202211:04AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
09/14/202211:04AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
09/14/202211:03AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
09/14/20227:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
09/14/20227:30AMGlobeNewswire Inc.Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.NASDAQ:JMACMaxpro Capital Acquisition Corporation
02/14/20223:15PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JMACMaxpro Capital Acquisition Corporation
01/13/20223:06PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JMACMaxpro Capital Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:JMAC

Your Recent History

Delayed Upgrade Clock